Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


30.01.2017

8 Anticancer Res
1 Biochem Biophys Res Commun
2 BMC Cancer
2 Dig Dis
1 Gut
5 Hepatology
2 J Gastroenterol Hepatol
10 J Hepatol
1 N Engl J Med
1 Oncogene
1 Pol J Radiol
2 Proc Natl Acad Sci U S A
2 Radiology
3 Transplant Proc
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. SEMAAN A, Branchi V, Marowsky AL, VON Websky M, et al
    Incidentally Detected Focal Liver Lesions - A Common Clinical Management Dilemma Revisited.
    Anticancer Res. 2016;36:2923-32.
    PubMed     Text format     Abstract available

  2. BRADATSCH A, Kornprat P, Bacher H, Cerwenka H, et al
    The Value of Lymph Node Dissection in the Surgery of Colorectal Cancer Liver Metastases.
    Anticancer Res. 2016;36:2993-7.
    PubMed     Text format     Abstract available

  3. MATSUI T, Nagata N, Hirata K, Okazaki S, et al
    Bi-weekly Capecitabine-Oxaliplatin (XELOX) plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer -The PHOENiX Trial.
    Anticancer Res. 2016;36:3437-43.
    PubMed     Text format     Abstract available

  4. DJAAFAR S, Dunand-Sautier I, Gonelle-Gispert C, Lacotte S, et al
    Enoxaparin Attenuates Mouse Colon Cancer Liver Metastases by Inhibiting Heparanase and Interferon-gamma-inducible Chemokines.
    Anticancer Res. 2016;36:4019-32.
    PubMed     Text format     Abstract available

  5. CHANG CD, Lin PY, Hsu JL, Shih WL, et al
    Ursolic Acid Suppresses Hepatitis B Virus X Protein-mediated Autophagy and Chemotherapeutic Drug Resistance.
    Anticancer Res. 2016;36:5097-5107.
    PubMed     Text format     Abstract available

  6. RADES D, Bolm L, Schild SE, Bartscht T, et al
    Survival Following Palliative External-beam Radiotherapy of Locally Advanced and Metastatic Liver Cancer.
    Anticancer Res. 2017;37:203-206.
    PubMed     Text format     Abstract available

  7. FUJIYOSHI K, Yamamoto G, Takenoya T, Takahashi A, et al
    Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
    Anticancer Res. 2017;37:239-247.
    PubMed     Text format     Abstract available

  8. RATHMANN N, Budjan J, Mari F, Grimm R, et al
    Semiautomatic Whole-lesion Apparent Diffusion Coefficient Assessment for Early Prediction of Liver Tumor Response to Radioembolization.
    Anticancer Res. 2016;36:2961-6.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  9. YU M, Liu Y, Duan Y, Chen Y, et al
    Inhibition of glutathione production by L-S,R-buthionine sulfoximine activates hepatic ascorbate synthesis-A unique anti-oxidative stress mechanism in mice.
    Biochem Biophys Res Commun. 2017 Jan 20. pii: S0006-291X(17)30106.
    PubMed     Text format     Abstract available


    BMC Cancer

  10. LI B, Zhang Y, Wu W, Du G, et al
    Neovascularization of hepatocellular carcinoma in a nude mouse orthotopic liver cancer model: a morphological study using X-ray in-line phase-contrast imaging.
    BMC Cancer. 2017;17:73.
    PubMed     Text format     Abstract available

  11. LI K, Su Z, Xu E, Huang Q, et al
    Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
    BMC Cancer. 2017;17:61.
    PubMed     Text format     Abstract available


    Dig Dis

  12. KOYAMA Y, Xu J, Liu X, Brenner DA, et al
    New Developments on the Treatment of Liver Fibrosis.
    Dig Dis. 2016;34:589-96.
    PubMed     Text format     Abstract available

  13. HALILBASIC E, Fuchs C, Traussnigg S, Trauner M, et al
    Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver Disease.
    Dig Dis. 2016;34:580-588.
    PubMed     Text format     Abstract available


    Gut

  14. ALVAREZ-SOLA G, Uriarte I, Latasa MU, Fernandez-Barrena MG, et al
    Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration.
    Gut. 2017 Jan 24. pii: gutjnl-2016-312975. doi: 10.1136/gutjnl-2016-312975.
    PubMed     Text format     Abstract available


    Hepatology

  15. STEINMETZ C, Kashyap A, Zhivkova N, Alizor H, et al
    Activation of SIRT1 by human chorionic gonadotropin exerts a therapeutic effect on hepatic injury and inflammation.
    Hepatology. 2017 Jan 21. doi: 10.1002/hep.29072.
    PubMed     Text format     Abstract available

  16. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:399-400.
    PubMed     Text format    

  17. HARGROVE L, Kennedy L, Demieville J, Jones H, et al
    BDL-induced biliary hyperplasia, hepatic injury and fibrosis are reduced in mast cell deficient Kitw-sh mice.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29079.
    PubMed     Text format     Abstract available

  18. SHIMIZU Y, Peltzer N, Sevko A, Lafont E, et al
    The linear ubiquitin chain assembly complex acts as a liver tumor suppressor and inhibits hepatocyte apoptosis and hepatitis.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29074.
    PubMed     Text format     Abstract available

  19. SABATE A, Blasi A
    Thromboelastography and blood product usage in cirrhosis with severe coagulopathy.
    Hepatology. 2017 Jan 19. doi: 10.1002/hep.29061.
    PubMed     Text format    


    J Gastroenterol Hepatol

  20. ZHOU D, Pan Q, Liu XL, Yang RX, et al
    Clostridium butyricum B1 alleviates high-fat diet-induced steatohepatitis in mice via enterohepatic immunoregulation.
    J Gastroenterol Hepatol. 2017 Jan 20. doi: 10.1111/jgh.13742.
    PubMed     Text format     Abstract available

  21. SEKI A, Ikeda F, Miyatake H, Takaguchi K, et al
    Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis.
    J Gastroenterol Hepatol. 2017 Jan 23. doi: 10.1111/jgh.13746.
    PubMed     Text format     Abstract available


    J Hepatol

  22. HEIER EC, Meier A, Julich-Haertel H, Djudjaj S, et al
    Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis.
    J Hepatol. 2017 Jan 17. pii: S0168-8278(17)30012.
    PubMed     Text format     Abstract available

  23. MOEINI A, Sia D, Zhang Z, Camprecios G, et al
    Mixed hepatocellular-cholangiocarcinoma tumors: cholangiolocellular carcinoma is a distinct molecular entity.
    J Hepatol. 2017 Jan 23. pii: S0168-8278(17)30014.
    PubMed     Text format     Abstract available

  24. SHERON N
    Alcohol and liver disease in Europe--Simple measures have the potential to prevent tens of thousands of premature deaths.
    J Hepatol. 2016;64:957-67.
    PubMed     Text format     Abstract available

  25. JUNKER AE, Gluud LL, van Hall G, Holst JJ, et al
    Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease.
    J Hepatol. 2016;64:908-15.
    PubMed     Text format     Abstract available

  26. GHALLAB A, Celliere G, Henkel SG, Driesch D, et al
    Model-guided identification of a therapeutic strategy to reduce hyperammonemia in liver diseases.
    J Hepatol. 2016;64:860-71.
    PubMed     Text format     Abstract available

  27. JURIC V, Ruffell B, Evason KJ, Hu J, et al
    Monocytes promote liver carcinogenesis in an oncogene-specific manner.
    J Hepatol. 2016;64:881-90.
    PubMed     Text format     Abstract available

  28. WESTBROOK RH, Dusheiko G, Williamson C
    Pregnancy and liver disease.
    J Hepatol. 2016;64:933-45.
    PubMed     Text format     Abstract available

  29. HONG G, Suh KS, Suh S, Yoo T, et al
    Preoperative Alpha-fetoprotein and F-FDG PET Predict Tumor Recurrence better than Milan Criteria in Living Donor Liver Transplantation.
    J Hepatol. 2015 Nov 30. pii: S0168-8278(15)00791.
    PubMed     Text format     Abstract available

  30. YIN H, Bogorad RL, Barnes C, Walsh S, et al
    RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.
    J Hepatol. 2016;64:899-907.
    PubMed     Text format     Abstract available

  31. WIESER V, Tymoszuk P, Adolph TE, Grander C, et al
    Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease.
    J Hepatol. 2016;64:872-80.
    PubMed     Text format     Abstract available


    N Engl J Med

  32. GE PS, Runyon BA
    Treatment of Patients with Cirrhosis.
    N Engl J Med. 2016;375:2104-5.
    PubMed     Text format    


    Oncogene

  33. HERMANNS C, Hampl V, Holzer K, Aigner A, et al
    The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    Pol J Radiol

  34. OGUNTOYE OO, Ndububa DA, Yusuf M, Bolarinwa RA, et al
    Hepatobiliary Ultrasonographic Abnormalities in Adult Patients with Sickle Cell Anaemia in Steady State in Ile-Ife, Nigeria.
    Pol J Radiol. 2017;82:1-8.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  35. KODAMA T, Newberg JY, Kodama M, Rangel R, et al
    Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma.
    Proc Natl Acad Sci U S A. 2016;113:E3384-93.
    PubMed     Text format     Abstract available

  36. ALONSO-MERINO E, Martin Orozco R, Ruiz-Llorente L, Martinez-Iglesias OA, et al
    Thyroid hormones inhibit TGF-beta signaling and attenuate fibrotic responses.
    Proc Natl Acad Sci U S A. 2016;113:E3451-60.
    PubMed     Text format     Abstract available


    Radiology

  37. YIN M, Glaser KJ, Manduca A, Mounajjed T, et al
    Distinguishing between Hepatic Inflammation and Fibrosis with MR Elastography.
    Radiology. 2017 Jan 27:160622. doi: 10.1148/radiol.2017160622.
    PubMed     Text format     Abstract available

  38. MIRAGLIA R, Maruzzelli L, Tuzzolino F, Petridis I, et al
    Transjugular Intrahepatic Portosystemic Shunts in Patients with Cirrhosis with Refractory Ascites: Comparison of Clinical Outcomes by Using 8- and 10-mm PTFE-covered Stents.
    Radiology. 2017 Jan 25:161644. doi: 10.1148/radiol.2017161644.
    PubMed     Text format     Abstract available


    Transplant Proc

  39. SERRANO OK, Cunha RD, Mettler T, Sutherland DE, et al
    Sinistral Portal Hypertension After Live Segmental Pancreas Donation: A Long-Term Sequelae Presenting With Life-Threatening Upper Gastrointestinal Hemorrhage.
    Transplant Proc. 2017;49:221-224.
    PubMed     Text format     Abstract available

  40. HSU HC, Enosawa S, Yamazaki T, Tohyama S, et al
    Enhancing Survival of Human Hepatocytes by Neonatal Thymectomy and Partial Hepatectomy in Micro-miniature Pigs.
    Transplant Proc. 2017;49:153-158.
    PubMed     Text format     Abstract available

  41. TANIMINE N, Tanaka Y, Abe T, Piao J, et al
    MELD and Child-Pugh Scores Are Related to Immune Status of Intrahepatic Natural Killer Cells in Liver Transplant Candidates.
    Transplant Proc. 2017;49:98-101.
    PubMed     Text format     Abstract available


    Transplantation

  42. BITTERMANN T, Goldberg DS, Bauer CM, Khungar V, et al
    Characterizing the risk of false-positive hepatocellular carcinoma in recipients transplanted with T2 MELD exceptions.
    Transplantation. 2017 Jan 25. doi: 10.1097/TP.0000000000001660.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: